A Randomized Clinical Trial of Transgender Women Switching to B/F/TAF: The (mo)BETTA Trial.
Jordan E LakeAna N MonczorHan FengPaula DebroyAaren KettelhutHongyu MiaoLiming PengShalender BhasinSusan BellNahid RianonTodd T BrownNicholas T FunderburgPublished in: Open forum infectious diseases (2023)
In this cohort of TW, switch to B/F/TAF was safe and metabolically neutral, though greater fat gain occurred on B/F/TAF. Further study is needed to better understand cardiometabolic disease burden in TW with HIV.
Keyphrases
- hiv testing
- hiv infected
- antiretroviral therapy
- adipose tissue
- hiv positive
- human immunodeficiency virus
- hepatitis c virus
- polycystic ovary syndrome
- hiv aids
- men who have sex with men
- clinical trial
- type diabetes
- phase iii
- randomized controlled trial
- pregnant women
- risk factors
- skeletal muscle
- cervical cancer screening
- placebo controlled